MCRB Historical PE Ratio image   This MCRB PE ratio history page last updated 5/10/2024
MCRB PE History Chart
PeriodPriceGAAPTTMPE
Q1 2024
5/8/2024
0.75-0.27-0.60NA
Q4 2023
3/5/2024
1.06-0.32-0.90NA
Q3 2023
11/2/2023
0.93-0.37-1.12NA
Q2 2023
8/8/2023
4.290.36-1.24NA
Q1 2023
5/9/2023
5.57-0.57-2.30NA
Q4 2022
3/7/2023
5.40-0.54-2.34NA
Q3 2022
11/2/2022
8.19-0.49-2.35NA
Q2 2022
8/3/2022
4.45-0.70-1.14NA
Q1 2022
5/4/2022
4.72-0.61-0.97NA
Q4 2021
3/1/2022
7.39-0.55-0.75NA
Q3 2021
11/10/2021
8.270.72-0.39NA
Q2 2021
8/3/2021
6.96-0.53-1.47NA
Q1 2021
5/4/2021
21.48-0.39-1.22NA
Q4 2020
3/2/2021
19.62-0.19-1.11NA
Q3 2020
11/9/2020
33.24-0.36-1.17NA
Q2 2020
7/28/2020
3.99-0.28-1.04NA
Q1 2020
5/7/2020
4.27-0.28-1.00NA
Q4 2019
3/2/2020
3.23-0.25-1.31NA
Q3 2019
11/5/2019
4.06-0.23-1.58NA
Q2 2019
8/6/2019
2.29-0.24-1.89NA
Q1 2019
5/2/2019
5.35-0.59-2.33NA
Q4 2018
3/6/2019
6.12-0.52-2.43NA
Q3 2018
11/8/2018
8.88-0.54-2.63NA
Q2 2018
8/2/2018
7.41-0.68-2.26NA
Q1 2018
5/9/2018
8.18-0.69-2.27NA
Q4 2017
3/8/2018
9.74-0.72-2.21NA
Q3 2017
11/8/2017
9.98-0.17-2.12NA
Q2 2017
8/3/2017
12.91-0.69-2.41NA
Q1 2017
5/4/2017
10.56-0.63-2.42NA
Q4 2016
3/16/2017
12.71-0.63-2.29NA
Q3 2016
11/10/2016
12.99-0.46NANA
Q2 2016
8/11/2016
9.73-0.70NANA
Q1 2016
5/16/2016
24.95-0.50NANA
MCRB Historical PE Ratio Chart
PeriodPriceGAAPAnnualizedPE
Q1 2024
5/8/2024
0.75-0.27-1.08NA
Q4 2023
3/5/2024
1.06-0.32-1.28NA
Q3 2023
11/2/2023
0.93-0.37-1.48NA
Q2 2023
8/8/2023
4.290.361.443.0
Q1 2023
5/9/2023
5.57-0.57-2.28NA
Q4 2022
3/7/2023
5.40-0.54-2.16NA
Q3 2022
11/2/2022
8.19-0.49-1.96NA
Q2 2022
8/3/2022
4.45-0.70-2.80NA
Q1 2022
5/4/2022
4.72-0.61-2.44NA
Q4 2021
3/1/2022
7.39-0.55-2.20NA
Q3 2021
11/10/2021
8.270.722.882.9
Q2 2021
8/3/2021
6.96-0.53-2.12NA
Q1 2021
5/4/2021
21.48-0.39-1.56NA
Q4 2020
3/2/2021
19.62-0.19-0.76NA
Q3 2020
11/9/2020
33.24-0.36-1.44NA
Q2 2020
7/28/2020
3.99-0.28-1.12NA
Q1 2020
5/7/2020
4.27-0.28-1.12NA
Q4 2019
3/2/2020
3.23-0.25-1.00NA
Q3 2019
11/5/2019
4.06-0.23-0.92NA
Q2 2019
8/6/2019
2.29-0.24-0.96NA
Q1 2019
5/2/2019
5.35-0.59-2.36NA
Q4 2018
3/6/2019
6.12-0.52-2.08NA
Q3 2018
11/8/2018
8.88-0.54-2.16NA
Q2 2018
8/2/2018
7.41-0.68-2.72NA
Q1 2018
5/9/2018
8.18-0.69-2.76NA
Q4 2017
3/8/2018
9.74-0.72-2.88NA
Q3 2017
11/8/2017
9.98-0.17-0.68NA
Q2 2017
8/3/2017
12.91-0.69-2.76NA
Q1 2017
5/4/2017
10.56-0.63-2.52NA
Q4 2016
3/16/2017
12.71-0.63-2.52NA
Q3 2016
11/10/2016
12.99-0.46-1.84NA
Q2 2016
8/11/2016
9.73-0.70-2.80NA
Q1 2016
5/16/2016
24.95-0.50-2.00NA
Quotes delayed 20 minutes

Email EnvelopeFree MCRB Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Seres Therapeutics (MCRB) is categorized under the Healthcare sector; to help you further research PE history across stocks, below are some other companies in the same sector:

MD PE Ratio History
MDGL PE Ratio History
MDT PE Ratio History
MDXG PE Ratio History
ME PE Ratio History
MEDP PE Ratio History
MEIP PE Ratio History
MGLN PE Ratio History
MGNX PE Ratio History
MGTA PE Ratio History
On this page we presented the MCRB PE Ratio History information for Seres Therapeutics' stock. The average MCRB PE ratio history based on using the annualized quarterly earnings result at each measurement period (for the "E" in the PE calculation; and the closing price on earnings date as the "P") is 3.0. Meanwhile, using the trailing twelve month (TTM) quarterly earnings result as our method of calculation the "E" value at each measurement period, the average MCRB PE ratio history based on this TTM earnings result method is NA. Note: any PE calculations involving negative earnings were discarded as not meaningful.

Let's now compare this MCRB PE ratio history result, against the recent PE: when this page was posted on 5/9/2024, the most recent closing price for MCRB had been 1.03, and the most recent quarterly earnings result, annualized, was 1.44. Meanwhile, the most recent TTM earnings summed to NA. From these numbers, we calculate the recent MCRB PE on 5/9/2024 based on annualized quarterly EPS was 0.7. Based on MCRB's history, that recent PE is low relative to the historical average, with the recent PE 76.7% lower than the historical average PE across our data set for Seres Therapeutics.

For self directed investors doing their due diligence on MCRB or any other given stock, valuation analysis for MCRB can greatly benefit from studying the past earnings and resulting PE ratio history calculations. This type of study can help inform an analysis as to whether the earnings trajectory over time and current versus historical average PE ratios justify the current stock market value.

That's why we bring you HistoricalPERatio.com to make it easy for investors to investigate Seres Therapeutics PE ratio history — or the PE history for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for next earnings dates and also historical earnings surprises history for MCRB. Thanks for visiting, and the next time you need to research MCRB PE Ratio History or the PE ratio history for another stock, we hope our site will come to mind as your go-to PE ratio history research resource of choice.

Recommended: DLBL YTD Return, NXC shares outstanding history, GVHR Videos.

 

MCRB PE Ratio History | www.HistoricalPERatio.com | Copyright © 2020 - 2024, All Rights Reserved

Nothing in HistoricalPERatio.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.